65 research outputs found
ICP2: THE RELATIVE EFFECTIVENESS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND TRICYCLIC ANTIDEPRESSANTS (TCAS) IN REDUCING WORKER ABSENTEEISM
Get PDFPDB25 THE ECONOMIC IMPACT OF WEIGHT LOSS FOR PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS (T2DM) IN THE US
Get PDFPUK2 TREATMENT PERSISTENCE OF OXYBUTYNIN XL AND TOLTERODINE IR IN A REAL-WORLD CLINICAL PRACTICE SETTING: DATA FROM THE UNITED KINGDOM
Get PDFPDB40 The Importance of HbA1C Evolution in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus (T2DM)
Get PDFPDB6 A Network Meta-Analysis (NMA) to Assess the Longer-Term Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin
Get PDFCost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States
Get PDF
ICP2: THE RELATIVE EFFECTIVENESS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND TRICYCLIC ANTIDEPRESSANTS (TCAS) IN REDUCING WORKER ABSENTEEISM
No full textDB4 RETROSPECTIVE STUDY OF TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS NOT OPTIMALLY CONTROLLED BY METFORMIN MONOTHERAPY
No full textComparative Persistency with Newer agents used to Treat Type 2 Diabetes (T2dm) In the united states: canagliflozin Versus Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors and Glucagon-Like Peptide-1 (Glp-1) agonists
No full text- …
